Vaccine Manufacturing

GeoVax Calls for Urgent Investment in Domestic Vaccine Manufacturing Amid Global Health Threats

GeoVax Calls for Urgent Investment in Domestic Vaccine Manufacturing Amid Global Health Threats

GeoVax Labs emphasizes the critical need for U.S. investment in domestic vaccine production and diversification to address the vulnerabilities exposed by global health crises like Mpox and COVID-19 variants.

July 30, 2025
GeoVax's New Vaccine Manufacturing Process Could Revolutionize Global Access to Critical Vaccines

GeoVax's New Vaccine Manufacturing Process Could Revolutionize Global Access to Critical Vaccines

GeoVax Labs has developed an advanced manufacturing process for MVA vaccines that eliminates dependency on pathogen-free eggs, potentially transforming vaccine production capabilities worldwide while reducing costs and increasing accessibility.

February 4, 2025